Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2021 | 01-2021 | 10-2020 | 07-2020 | 04-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -31,288 | -21,241 | -10,814 | N/A |
| Depreciation Amortization | N/A | 644 | 398 | 196 | N/A |
| Accounts payable and accrued liabilities | N/A | -1,182 | 446 | 35 | N/A |
| Other Working Capital | N/A | 8,449 | 7,134 | 6,336 | N/A |
| Other Operating Activity | 0 | 4,251 | 1,723 | 659 | 0 |
| Operating Cash Flow | $N/A | $-19,126 | $-11,540 | $-3,588 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -49 | -35 | -22 | N/A |
| Purchase Of Investment | N/A | -26,814 | -19,342 | -9,807 | N/A |
| Sale Of Investment | N/A | 45,692 | 31,261 | 15,342 | N/A |
| Investing Cash Flow | $N/A | $18,829 | $11,884 | $5,513 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 1,809 | 106 | 46 | N/A |
| Financing Cash Flow | $N/A | $1,809 | $106 | $46 | $N/A |
| Exchange Rate Effect | N/A | 426 | -65 | 254 | N/A |
| Beginning Cash Position | N/A | 15,789 | 15,789 | 15,789 | N/A |
| End Cash Position | N/A | 17,727 | 16,174 | 18,014 | N/A |
| Net Cash Flow | $N/A | $1,938 | $385 | $2,225 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -19,126 | -11,540 | -3,588 | N/A |
| Capital Expenditure | N/A | -49 | -35 | -22 | N/A |
| Free Cash Flow | 0 | -19,175 | -11,575 | -3,610 | 0 |